DRUG · Unmapped registry intervention
TCHP
Find medicine records ·
Find other trials using this name
Clinical trial
TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer
NCT04094896
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedTCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HER2-Positive Breast Cancerunresolved
Interventions
TCHPDRUG
Sponsors & collaborators
Guangdong Provincial People's Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04094896 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.